{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:21:20Z","timestamp":1785205280712,"version":"3.55.0"},"reference-count":35,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.3892\/ijo.2016.3338","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T05:39:35Z","timestamp":1452749975000},"page":"1073-1084","source":"Crossref","is-referenced-by-count":8,"title":["Quinalizarin enhances radiosensitivity of nasopharyngeal carcinoma cells partially by suppressing SHP-1 expression"],"prefix":"10.3892","volume":"48","author":[{"given":"XIAOFEN","family":"PAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RUI","family":"MENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHONGHUA","family":"YU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JINGJING","family":"MOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHA","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZIYI","family":"SUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHENWEI","family":"ZOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GANG","family":"WU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GANG","family":"PENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,1,14]]},"reference":[{"key":"key20180107184942_b1-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1158\/0008-5472.CAN-09-4099","article-title":"Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics","volume":"70","author":"Feng","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107184942_b2-ijo-48-03-1073","first-page":"357027","article-title":"Imatinib: A breakthrough of targeted therapy in cancer","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Chemother Res Pract"},{"key":"key20180107184942_b3-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nature03095","article-title":"Targeted cancer therapy","volume":"432","author":"Sawyers","year":"2004","journal-title":"Nature"},{"key":"key20180107184942_b4-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cellsig.2010.01.011","article-title":"Kinases as targets in the treatment of solid tumors","volume":"22","author":"Giamas","year":"2010","journal-title":"Cell Signal"},{"key":"key20180107184942_b5-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.ejca.2014.04.015","article-title":"Review of therapeutic drug monitoring of anticancer drugs part two - targeted therapies","volume":"50","author":"Widmer","year":"2014","journal-title":"Eur J Cancer"},{"key":"key20180107184942_b6-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/biof.96","article-title":"Emergence of protein kinase CK2 as a key target in cancer therapy","volume":"36","author":"Trembley","year":"2010","journal-title":"Biofactors"},{"key":"key20180107184942_b7-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"18394","DOI":"10.1074\/jbc.M601112200","article-title":"Casein kinase 2 is activated and essential for Wnt\/beta-catenin signaling","volume":"281","author":"Gao","year":"2006","journal-title":"J Biol Chem"},{"key":"key20180107184942_b8-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1013108822847","article-title":"Protein kinase CK2: Signaling and tumorigenesis in the mammary gland","volume":"227","author":"Landesman-Bollag","year":"2001","journal-title":"Mol Cell Biochem"},{"key":"key20180107184942_b9-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1007\/s00018-009-9154-y","article-title":"Protein kinase CK2 in health and disease: CK2: a key player in cancer biology","volume":"66","author":"Trembley","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"key20180107184942_b10-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1128\/MCB.01246-10","article-title":"ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells","volume":"31","author":"Hagan","year":"2011","journal-title":"Mol Cell Biol"},{"key":"key20180107184942_b11-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11010-009-0216-0","article-title":"Inhibition of protein kinase CK2 expression and activity blocks tumor cell growth","volume":"333","author":"Zhu","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"key20180107184942_b12-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/jcb.23247","article-title":"Protein kinase CK2 promotes cancer cell viability via up-regulation of cyclooxygenase-2 expression and enhanced prostaglandin E2 production","volume":"112","author":"Yefi","year":"2011","journal-title":"J Cell Biochem"},{"key":"key20180107184942_b13-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2199-13-7","article-title":"Protein kinase CK2 localizes to sites of DNA double-strand break regulating the cellular response to DNA damage","volume":"13","author":"Olsen","year":"2012","journal-title":"BMC Mol Biol"},{"key":"key20180107184942_b14-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/cbr.2010.0917","article-title":"CK2 inhibitors enhance the radiosensitivity of human non-small cell lung cancer cells through inhibition of stat3 activation","volume":"26","author":"Lin","year":"2011","journal-title":"Cancer Biother Radiopharm"},{"key":"key20180107184942_b15-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1042\/BJ20080309","article-title":"The selectivity of inhibitors of protein kinase CK2: An update","volume":"415","author":"Pagano","year":"2008","journal-title":"Biochem J"},{"key":"key20180107184942_b16-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/BJ20090069","article-title":"Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2","volume":"421","author":"Cozza","year":"2009","journal-title":"Biochem J"},{"key":"key20180107184942_b17-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1042\/bj20030674","article-title":"Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihy-droindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA)","volume":"374","author":"Sarno","year":"2003","journal-title":"Biochem J"},{"key":"key20180107184942_b18-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-065X.2008.00760.x","article-title":"SHP-1 and SHP-2 in T cells: Two phosphatases functioning at many levels","volume":"228","author":"Lorenz","year":"2009","journal-title":"Immunol Rev"},{"key":"key20180107184942_b19-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/geno.1995.1020","article-title":"Human protein tyrosine phosphatase 1C (PTPN6) gene structure: Alternate promoter usage and exon skipping generate multiple transcripts","volume":"27","author":"Banville","year":"1995","journal-title":"Genomics"},{"key":"key20180107184942_b20-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ygeno.2013.10.001","article-title":"Characterization of SHP-1 protein tyrosine phosphatase transcripts, protein isoforms and phosphatase activity in epithelial cancer cells","volume":"102","author":"Evren","year":"2013","journal-title":"Genomics"},{"key":"key20180107184942_b21-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1189\/jlb.0608383","article-title":"Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells","volume":"85","author":"Nakase","year":"2009","journal-title":"J Leukoc Biol"},{"key":"key20180107184942_b22-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1084\/jem.186.9.1575","article-title":"Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes","volume":"186","author":"Delibrias","year":"1997","journal-title":"J Exp Med"},{"key":"key20180107184942_b23-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0002-9440(10)62535-7","article-title":"Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas\/leukemias: Combination analysis with cDNA expression array and tissue microarray","volume":"159","author":"Oka","year":"2001","journal-title":"Am J Pathol"},{"key":"key20180107184942_b24-ijo-48-03-1073","first-page":"251","article-title":"A long survival case of small cell lung cancer synchronized with renal cancer]","volume":"44","author":"Sato","year":"1991","journal-title":"Kyobu Geka"},{"key":"key20180107184942_b25-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/path.2178","article-title":"Decreased expression level of SH2 domain-containing protein tyrosine phosphatase-1 (Shp1) is associated with progression of chronic myeloid leukemia","volume":"212","author":"Amin","year":"2007","journal-title":"J Pathol"},{"key":"key20180107184942_b26-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/187152011794941154","article-title":"SHP-1 in cell-cycle regulation","volume":"11","author":"L\u00f3pez-Ruiz","year":"2011","journal-title":"Anticancer Agents Med Chem"},{"key":"key20180107184942_b27-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2478\/raon-2014-0001","article-title":"Increased expression of SHP-1 is associated with local recurrence after radiotherapy in patients with nasopharyngeal carcinoma","volume":"48","author":"Peng","year":"2014","journal-title":"Radiol Oncol"},{"key":"key20180107184942_b28-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.3892\/mmr.2014.2463","article-title":"Alterations of cell cycle control proteins SHP-1\/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cells","volume":"10","author":"Peng","year":"2014","journal-title":"Mol Med Rep"},{"key":"key20180107184942_b29-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1748-717X-8-178","article-title":"SHP1-mediated cell cycle redistribution inhibits radiosensitivity of non-small cell lung cancer","volume":"8","author":"Cao","year":"2013","journal-title":"Radiat Oncol"},{"key":"key20180107184942_b30-ijo-48-03-1073","article-title":"Cell survival curves","volume-title":"Radiobiology for the Radiologist","author":"Hall","year":"2011"},{"key":"key20180107184942_b31-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.3892\/mmr.2014.2463","article-title":"Alterations of cell cycle control proteins SHP-1\/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cells","volume":"10","author":"Peng","year":"2014","journal-title":"Mol Med Rep"},{"key":"key20180107184942_b32-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3892\/ijo.2012.1489","article-title":"Casein kinase 2 inhibition modulates the DNA damage response but fails to radiosensitize malignant glioma cells","volume":"41","author":"Kroonen","year":"2012","journal-title":"Int J Oncol"},{"key":"key20180107184942_b33-ijo-48-03-1073","first-page":"1551","article-title":"Effect of protein kinase CK2 gene silencing on radiosensitization in human nasopharyngeal carcinoma cells","volume":"29","author":"Liu","year":"2009","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"key20180107184942_b34-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.3892\/or.2015.3939","article-title":"SHP-1 overexpression increases the radioresistance of NPC cells by enhancing DSB repair, increasing S phase arrest and decreasing cell apoptosis","volume":"33","author":"Pan","year":"2015","journal-title":"Oncol Rep"},{"key":"key20180107184942_b35-ijo-48-03-1073","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(03)00400-1","article-title":"The function of the protein tyrosine phosphatase SHP-1 in cancer","volume":"306","author":"Wu","year":"2003","journal-title":"Gene"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2016.3338\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T13:52:29Z","timestamp":1515333149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2016.3338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,14]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,1,14]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.3892\/ijo.2016.3338"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2016.3338","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,14]]}}}